🇺🇸 FDA
Pipeline program

High Dose SAB-142

SAB-142-201

Phase 2 small_molecule active

Quick answer

High Dose SAB-142 for Type 1 Diabetes is a Phase 2 program (small_molecule) at SAB Biotherapeutics with 1 ClinicalTrials.gov record(s).

Program details

Company
SAB Biotherapeutics
Indication
Type 1 Diabetes
Phase
Phase 2
Modality
small_molecule
Status
active

Clinical trials